Patrick Hwu: A celebration of hope and a shared mission to support Moffitt’s fight against cancer
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared a post LinkedIn:
“The ReMissions, Moffitt Cancer Center’s house band, just released our debut holiday vinyl album, ‘Happy Holidays with The ReMissions!’.
This project is more than just music; it’s a celebration of hope, teamwork and a shared mission to support Moffitt’s fight against cancer.
Order your limited-edition vinyl today to support cancer research and be a part of Moffitt’s mission.”
Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.
Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023